These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549 [TBL] [Abstract][Full Text] [Related]
68. Leukopenia induced by leuprolide acetate depot. Grau E; Torrecilla T; Real E; Sempere J Ann Pharmacother; 1994 Feb; 28(2):283-4. PubMed ID: 8173155 [No Abstract] [Full Text] [Related]
69. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. Sherwin BB; Tulandi T J Clin Endocrinol Metab; 1996 Jul; 81(7):2545-9. PubMed ID: 8675575 [TBL] [Abstract][Full Text] [Related]
71. Recurrence of myomas after myomectomy in women pretreated with leuprolide acetate depot or placebo. Friedman AJ; Daly M; Juneau-Norcross M; Fine C; Rein MS Fertil Steril; 1992 Jul; 58(1):205-8. PubMed ID: 1624009 [TBL] [Abstract][Full Text] [Related]
72. The concentrations of collagen-associated amino acids are higher in GnRH agonist-treated uterine myomas. Rein MS; Barbieri RL; Welch W; Gleason RE; Caulfield JP; Friedman AJ Obstet Gynecol; 1993 Dec; 82(6):901-5. PubMed ID: 8233262 [TBL] [Abstract][Full Text] [Related]
73. [GnRH analogues and myomas: which strategy?]. Poncelet C Gynecol Obstet Fertil; 2005 Dec; 33(12):1018. PubMed ID: 16316770 [No Abstract] [Full Text] [Related]
74. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy. Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826 [TBL] [Abstract][Full Text] [Related]
75. [Short-term treatment with leuprolide acetate depot before surgical intervention for uterine leiomyomatosis]. D'Anna R; Palmara V; Lo Re C; Scilipoti A; Leonardi I Minerva Ginecol; 1994 Jun; 46(6):343-6. PubMed ID: 7936386 [TBL] [Abstract][Full Text] [Related]
76. The effect of chronic gonadotropin-releasing hormone analog (D-Trp-6) treatment on elevated and normal serum prolactin levels. Golan A; Bukovsky I; Weinraub Z; Ron-El R; Herman A; Raziel A; Caspi E Fertil Steril; 1989 Mar; 51(3):532-4. PubMed ID: 2522065 [TBL] [Abstract][Full Text] [Related]
79. Leuprolide acetate depot decreases the number of nucleolar organizer regions in uterine leiomyomata. Barbieri RL; Dilena M; Chumas J; Rein MS; Friedman AJ Fertil Steril; 1993 Sep; 60(3):569-70. PubMed ID: 8375543 [TBL] [Abstract][Full Text] [Related]
80. Calcium homeostasis, bone metabolism and safety aspects during long-term treatment with a GnRH agonist. Eckstein N; Foldes J; Feinstein Y; Vagman I; Eshel A; Steinberg R; Statter M; Limor R; Ayalon D Maturitas; 1992 Aug; 15(1):25-32. PubMed ID: 1388219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]